| 10:31a | Minerva Neurosciences to Sell Royalty Interest in Depressive Disorder Drug; S.. | MT |
| 01:09a | JOHNSON & JOHNSON : Some Key Questions Answered On Covid-19 Vaccines for African.. | AQ |
| 01/18 | JOHNSON & JOHNSON : - DARZALEX FASPRO Becomes the First FDA-Approved Treatment f.. | AQ |
| 01/17 | FAUCI : U.S. 'weeks away' from evaluating new vaccine candidates | AQ |
| 01/15 | JOHNSON & JOHNSON : DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) Become.. | PU |
| 01/15 | GENMAB A/S : to Receive $30 Million Milestone Payment from Janssen Over FDA Appr.. | MT |
| 01/15 | "MY 2021 HEALTHCARE RESOLUTION" : 7 Johnson & Johnson Leaders Share Their Goals .. | PU |
| 01/14 | JOHNSON & JOHNSON : Statement on Political Contributions | PU |
| 01/14 | NEXTECH AR : sees $7.3M in business for Q4 | AQ |
| 01/14 | US Stocks Rise in Early Trading Amid Expectations of Surge in Consumer Spendi.. | MT |
| 01/14 | Presidency On Africa Centres for Disease Control and Prevention Securing Firs.. | AQ |
| 01/14 | The earnings season picks up steam | |
| 01/14 | THE COVID-19 DATA PLAN : 3 Innovative Ways Johnson & Johnson Is Using Data Scien.. | AQ |
| 01/14 | Invitae to Develop Standardized Panel to Detect Molecular Residual Disease as.. | MT |
| 01/14 | 270 Million Covid-19 Vaccine Doses Secured for Africa | AQ |
| 01/13 | JOHNSON & JOHNSON : Favorable Data Published About Johnson & Johnson Covid-19 Va.. | DJ |
| 01/13 | MARKET CHATTER : Johnson & Johnson One Dose Covid-19 Vaccine Shown to Be Safe, G.. | MT |
| 01/13 | JOHNSON & JOHNSON : Shares Higher After-Hours - One-Dose Covid-19 Vaccine Report.. | MT |
| 01/13 | JOHNSON & JOHNSON : COVID-19 Vaccine Candidate Interim Phase 1/2a Data Published.. | PU |
| 01/13 | JOHNSON & JOHNSON : African Union buys 270 million vaccine doses for continent | AQ |
| 01/13 | J&J vaccine on track for March rollout with target to deliver 1 bln doses thi.. | RE |
| 01/13 | J&J COVID-19 vaccine on track for March rollout, still aims for 1 bln doses t.. | RE |
| 01/13 | ESSA PHARMA : Janssen to Pursue Clinical Collaboration in Prostate Cancer Combin.. | MT |
| 01/13 | GLOBAL MARKETS LIVE: Qualcomm, Boeing, Visa… | |
| 01/13 | JOHNSON & JOHNSON : Janssen to Highlight Commitment to Lung Cancer Science and I.. | AQ |
| 01/12 | J&J Opposes Former Talc Supplier's Bankruptcy Plan to Resolve Cancer Claims | DJ |
| 01/12 | JOHNSON & JOHNSON : Janssen to Highlight Commitment to Lung Cancer Science and I.. | PU |
| 01/09 | The Cold Supply Chain Can't Reach Everywhere - That's a Big Problem for Equit.. | AQ |
| 01/08 | COVID-19 UPDATE : Your Latest Questions About Johnson & Johnson's Investigationa.. | AQ |
| 01/07 | The Vaccine Cold Supply Chain Can't Reach Everywhere | AQ |
| 01/07 | JOHNSON & JOHNSON : Statement by Alex Gorsky Johnson & Johnson Chairman and CEO | AQ |
| 01/05 | MORPHIC : Janssen Expand Collaboration on Integrin Program | MT |
| 01/04 | JOHNSON & JOHNSON : Announces Quarterly Dividend for First Quarter 2021 | PR |
| 2020 | JOHNSON & JOHNSON : Large US Pharma Franchises on Track to Beat Credit Suisse's .. | MT |
| 2020 | JOHNSON & JOHNSON : Zacks Adjusts Johnson & Johnson's Price Target to $161 from .. | MT |
| 2020 | JOHNSON & JOHNSON : Janssen Submits European Marketing Authorisation Application.. | AQ |
| 2020 | JOHNSON & JOHNSON : Unit Files Marketing Application in Europe for Lung Cancer T.. | MT |
| 2020 | US Stocks Advance in Holiday-Shortened Trade With Treasuries After UK, EU Rea.. | MT |
| 2020 | GLOBAL MARKETS LIVE : Alibaba, Merck, Moderna… | |
| 2020 | MARKET CHATTER : South Korea Secures Pfizer, Johnson & Johnson COVID-19 Vaccines.. | MT |
| 2020 | JOHNSON & JOHNSON : Disease-Free Survival Data from CAPTIVATE Study Demonstrate .. | PU |
| 2020 | JOHNSON & JOHNSON : Updated Results from the Phase 1 Study of the BCMAxCD3 Bispe.. | PU |
| 2020 | JOHNSON & JOHNSON : Early, Deep, Durable Responses of Ciltacabtagene Autoleucel .. | PU |
| 2020 | JOHNSON & JOHNSON : to Participate in the 39th Annual J.P. Morgan Healthcare Con.. | PU |
| 2020 | JOHNSON & JOHNSON : New Data Demonstrate Long-Term Benefit of IMBRUVICA® (ibruti.. | PU |
| 2020 | JOHNSON & JOHNSON : Janssen Submits Application to U.S. FDA Seeking Approval of .. | PU |
| 2020 | Pfizer In Talks With Malaysia for Additional Doses of COVID-19 Vaccine | MT |
| 2020 | BIOSTOCK : Iconovo address maternal health in partnership with Monash University | AQ |
| 2020 | GLOBAL MARKETS LIVE : Tesla, Bayer, Softbank... | |
| 2020 | JOHNSON & JOHNSON : Janssen Initiates Rolling Submission of a Biologics License .. | AQ |
| 2020 | JOHNSON & JOHNSON : Announces Agreement in Principle with Gavi to Supply Janssen.. | AQ |
| 2020 | JOHNSON & JOHNSON : to Host Investor Conference Call on Fourth-Quarter Results | AQ |
| 2020 | JOHNSON & JOHNSON : Janssen Initiates Rolling Submission of a Biologics License .. | PU |
| 2020 | GlaxoSmithKline Unit Secures European Marketing Approval for Long-Acting Inje.. | MT |
| 2020 | ICONOVO : signs agreement for development of inhaled oxytocin in ICOone for mate.. | AQ |
| 2020 | JOHNSON & JOHNSON : Changing "Date Of Status" And "First Reported Date" May Expo.. | AQ |
| 2020 | ASSISTANT U.S. HEALTH SECRETARY GIROIR SAYS EXPECTS NEXT COVID VACCINE CANDID.. | RE |
| 2020 | JOHNSON & JOHNSON : WHO's COVID-19 vaccine drive doubles global supply to 2 bill.. | AQ |
| 2020 | JOHNSON & JOHNSON : to Host Investor Conference Call on Fourth-Quarter Results | PU |
| 2020 | MACROGENICS : Enters Research Collaboration, License Agreement with J&J's Jansse.. | MT |
| 2020 | MACROGENICS : In Research, License Agreement With Janssen | DJ |
| 2020 | JOHNSON & JOHNSON : Announces Its First Phase 3 COVID-19 Vaccine Trial ENSEMBLE .. | AQ |
| 2020 | JOHNSON & JOHNSON : Completes Enrollment For Late-Stage Trial of COVID-19 Vaccin.. | MT |
| 2020 | JOHNSON & JOHNSON : Conference Chair from Johnson & Johnson Invites You to Atten.. | AQ |
| 2020 | JOHNSON & JOHNSON : Dow Jones, S&P 500 and Nasdaq Composite all hit record highs.. | AQ |
| 2020 | JOHNSON & JOHNSON : IP Rights Will Reduce Health Burden, Improve Economy, Expert.. | AQ |
| 2020 | Chile Approves Use of Pfizer's Covid-19 Vaccine | DJ |
| 2020 | PROTAGONIST THERAPEUTICS : Commences Phase 1 Trial of Oral IL-23 Receptor Antago.. | MT |
| 2020 | XBRANE BIOPHARMA : Nina Ivers joins Xbrane Biopharma as Head of HR | AQ |
| 2020 | JOHNSON & JOHNSON : Morgan Stanley Adjusts Price Target for Johnson & Johnson to.. | MT |
| 2020 | VERACYTE : Expands Partnership With Johnson & Johnson in Lung Cancer Detection S.. | MT |
| 2020 | JOHNSON & JOHNSON : to Participate in the 39th Annual J.P. Morgan Healthcare Con.. | PU |
| 2020 | Pfizer, BioNTech Covid-19 Vaccine Is Authorized in the U.S. -- 2nd Update | DJ |
| 2020 | Pfizer, BioNTech Covid-19 Vaccine Is Authorized -2- | DJ |
| 2020 | Pfizer, BioNTech Covid-19 Vaccine Is Authorized in the U.S. -- Update | DJ |
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
